José A. Burón

Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia

J.M. Olivares, Alfonso Rodríguez-Martínez, José A. Burón et al. · Applied Health Economics and Health Policy · 2008 · 65 citations

Cost-effectiveness Analysis, Psychiatry, Switching Antipsychotic Medication +8

Longitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: One-year follow-up from the Eiffel study

Rafael Segarra, Natalia Ojeda, Javier Peña et al. · European Psychiatry · 2010 · 60 citations

Incidence of tardive dyskinesia: a comparison of long‐acting injectable and oral paliperidone clinical trial databases

Srihari Gopal, Haiyan Xu, Cynthia A. Bossie et al. · International Journal of Clinical Practice · 2014 · 23 citations · Full text

Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study

Jesús de la Gándara, Luis San, Gabriel Rubio et al. · Expert Review of Neurotherapeutics · 2009 · 22 citations